Unfortunately, I fully agree.
That we are at this stage - still hammering out revenue/margins & after having apparently utilised the skills of Mr Mellor to establish the master licence is a very poor outcome. Horses are long gone.
This also means this area of our technology is locked in with P&G at,what appears to be less than favourable margins. We are now prevented from offering the technology to others at more equitable margins.
This situation would be far more palatable if management were able to leverage off the P&G partnership to secure other majors. I feel that focus & momentum was lost with back slapping over the P&G deal, & consequently the opportunity to rapidly secure & maximise our margins with other majors has been severely diminished.
GD's replacement? Where the hell is he/she?
- Forums
- ASX - By Stock
- WFL
- Higher base price before 2nd tech ann
Higher base price before 2nd tech ann, page-44
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online